Stay informed with the latest litigation news. Explore now

IP Verse

Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc - 2:23-cv-03530

Explore the details of the Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc case under case number 2:23-cv-03530 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
2:23-cv-03530
Filing Date
Jun 29, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD. -
BOEHRINGER INGELHEIM INTERNATIONAL GMBH -
ANOBRI PHARMACEUTICALS US, LLC -
NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

Docket entries not found - set an alert to get notified when docket entries are added.